Invention Grant
- Patent Title: Clinical diagnosis of non-alcoholic fatty liver disease using a panel of human blood protein biomarkers
-
Application No.: US16326737Application Date: 2017-08-23
-
Publication No.: US11366124B2Publication Date: 2022-06-21
- Inventor: Bevin Gangadharan , Abhinav Kumar , Raymond A. Dwek , Nicole Zitzmann , Mark Thursz , Jeremy Francis Lars Cobbold
- Applicant: Oxford University Innovation Limited
- Applicant Address: GB Oxford
- Assignee: Oxford University Innovation Limited
- Current Assignee: Oxford University Innovation Limited
- Current Assignee Address: GB Oxford
- Agency: Thomas|Horstemeyer, LLP
- Priority: GB1614455 20160824
- International Application: PCT/GB2017/052486 WO 20170823
- International Announcement: WO2018/037229 WO 20180301
- Main IPC: G01N33/68
- IPC: G01N33/68
Abstract:
The invention relates to methods of diagnosing, prognosing, or monitoring or staging the progression of non-alcoholic fatty liver disease (NAFLD) using biomarkers. The invention also relates to a method of scoring to determine the severity of NAFLD, and a method of treating NAFLD.
Public/Granted literature
- US20190339288A1 CLINICAL DIAGNOSIS OF NON-ALCOHOLIC FATTY LIVER DISEASE USING A PANEL OF HUMAN BLOOD PROTEIN BIOMARKERS Public/Granted day:2019-11-07
Information query
IPC分类:
